184 related articles for article (PubMed ID: 11131716)
1. Antiretroviral pharmacology in pregnant women and their newborns.
Mirochnick M
Ann N Y Acad Sci; 2000 Nov; 918():287-97. PubMed ID: 11131716
[TBL] [Abstract][Full Text] [Related]
2. Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial.
Dorenbaum A; Cunningham CK; Gelber RD; Culnane M; Mofenson L; Britto P; Rekacewicz C; Newell ML; Delfraissy JF; Cunningham-Schrader B; Mirochnick M; Sullivan JL;
JAMA; 2002 Jul; 288(2):189-98. PubMed ID: 12095383
[TBL] [Abstract][Full Text] [Related]
3. A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.
Moodley D; Moodley J; Coovadia H; Gray G; McIntyre J; Hofmyer J; Nikodem C; Hall D; Gigliotti M; Robinson P; Boshoff L; Sullivan JL;
J Infect Dis; 2003 Mar; 187(5):725-35. PubMed ID: 12599045
[TBL] [Abstract][Full Text] [Related]
4. Single-dose Nevirapine during pregnancy.
Sax PE
AIDS Clin Care; 1999 Oct; 11(10):84-5. PubMed ID: 11366708
[TBL] [Abstract][Full Text] [Related]
5. Zidovudine: a review of its use in the management of vertically-acquired pediatric HIV infection.
Bhana N; Ormrod D; Perry CM; Figgitt DP
Paediatr Drugs; 2002; 4(8):515-53. PubMed ID: 12126455
[TBL] [Abstract][Full Text] [Related]
6. Current treatment strategies, complications and considerations for the use of HIV antiretroviral therapy during pregnancy.
Senise JF; Castelo A; Martínez M
AIDS Rev; 2011; 13(4):198-213. PubMed ID: 21975356
[TBL] [Abstract][Full Text] [Related]
7. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
[TBL] [Abstract][Full Text] [Related]
8. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
; de Vincenzi I
Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
[TBL] [Abstract][Full Text] [Related]
9. A randomized, double-blind, placebo-controlled trial of combined nevirapine and zidovudine compared with nevirapine alone in the prevention of perinatal transmission of HIV in Zimbabwe.
Thistle P; Spitzer RF; Glazier RH; Pilon R; Arbess G; Simor A; Boyle E; Chitsike I; Chipato T; Gottesman M; Silverman M
Clin Infect Dis; 2007 Jan; 44(1):111-9. PubMed ID: 17143826
[TBL] [Abstract][Full Text] [Related]
10. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study.
Thior I; Lockman S; Smeaton LM; Shapiro RL; Wester C; Heymann SJ; Gilbert PB; Stevens L; Peter T; Kim S; van Widenfelt E; Moffat C; Ndase P; Arimi P; Kebaabetswe P; Mazonde P; Makhema J; McIntosh K; Novitsky V; Lee TH; Marlink R; Lagakos S; Essex M;
JAMA; 2006 Aug; 296(7):794-805. PubMed ID: 16905785
[TBL] [Abstract][Full Text] [Related]
11. Assessment of Nevirapine Prophylactic and Therapeutic Dosing Regimens for Neonates.
Cressey TR; Punyawudho B; Le Coeur S; Jourdain G; Saenjum C; Capparelli EV; Jittayanun K; Phanomcheong S; Luvira A; Borkird T; Puangsombat A; Aarons L; Sukrakanchana PO; Urien S; Lallemant M;
J Acquir Immune Defic Syndr; 2017 Aug; 75(5):554-560. PubMed ID: 28489732
[TBL] [Abstract][Full Text] [Related]
12. Nevirapine: a review of its use in the prevention and treatment of paediatric HIV infection.
Bardsley-Elliot A; Perry CM
Paediatr Drugs; 2000; 2(5):373-407. PubMed ID: 11022799
[TBL] [Abstract][Full Text] [Related]
13. Quantifying the impact of nevirapine-based prophylaxis strategies to prevent mother-to-child transmission of HIV-1: a combined pharmacokinetic, pharmacodynamic, and viral dynamic analysis to predict clinical outcomes.
Frank M; von Kleist M; Kunz A; Harms G; Schütte C; Kloft C
Antimicrob Agents Chemother; 2011 Dec; 55(12):5529-40. PubMed ID: 21947390
[TBL] [Abstract][Full Text] [Related]
14. Antiretroviral concentrations in breast-feeding infants of women in Botswana receiving antiretroviral treatment.
Shapiro RL; Holland DT; Capparelli E; Lockman S; Thior I; Wester C; Stevens L; Peter T; Essex M; Connor JD; Mirochnick M
J Infect Dis; 2005 Sep; 192(5):720-7. PubMed ID: 16088821
[TBL] [Abstract][Full Text] [Related]
15. A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006).
Musoke P; Guay LA; Bagenda D; Mirochnick M; Nakabiito C; Fleming T; Elliott T; Horton S; Dransfield K; Pav JW; Murarka A; Allen M; Fowler MG; Mofenson L; Hom D; Mmiro F; Jackson JB
AIDS; 1999 Mar; 13(4):479-86. PubMed ID: 10197376
[TBL] [Abstract][Full Text] [Related]
16. AIDS drug trials in Thailand and Uganda.
Simonds RJ
Nat Med; 1999 Nov; 5(11):1217. PubMed ID: 10545961
[No Abstract] [Full Text] [Related]
17. Pharmacokinetics of nevirapine in human immunodeficiency virus type 1-infected pregnant women and their neonates. Pediatric AIDS Clinical Trials Group Protocol 250 Team.
Mirochnick M; Fenton T; Gagnier P; Pav J; Gwynne M; Siminski S; Sperling RS; Beckerman K; Jimenez E; Yogev R; Spector SA; Sullivan JL
J Infect Dis; 1998 Aug; 178(2):368-74. PubMed ID: 9697716
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of short-term and long-term zidovudine prophylaxis on detection of HIV-1 subtype E in human placenta and vertical transmission.
Bhoopat L; Khunamornpong S; Lerdsrimongkol P; Sirivatanapa P; Sethavanich S; Limtrakul A; Gomutbuthra V; Kajanavanich S; Thorner PS; Bhoopat T
J Acquir Immune Defic Syndr; 2005 Dec; 40(5):545-50. PubMed ID: 16284530
[TBL] [Abstract][Full Text] [Related]
19. New studies of methods for preventing perinatal HIV transmission.
Hanna L
BETA; 1997 Mar; ():20. PubMed ID: 11364523
[TBL] [Abstract][Full Text] [Related]
20. Antiretroviral concentrations in breast-feeding infants of mothers receiving highly active antiretroviral therapy.
Mirochnick M; Thomas T; Capparelli E; Zeh C; Holland D; Masaba R; Odhiambo P; Fowler MG; Weidle PJ; Thigpen MC
Antimicrob Agents Chemother; 2009 Mar; 53(3):1170-6. PubMed ID: 19114673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
